Health X Platform Limited

Operating margins persistently negative (-1.87% to -7.5% across recent quarters) with ROE at 0.18% — verify path to profitability and whether current cash burn is sustainable

Low institutional participation (FII 2.29%, DII 2.6% combined 4.89%) may reflect information gap or weak institutional confidence — researcher should verify governance and disclosure adequacy

No dividend paid since 2011-12 despite ₹923 Cr market cap — verify whether cash generation remains insufficient or capital is retained for turnarounds

Data shows dual revenue scales per quarter (₹0.08–0.1 Cr and ₹300–446 Cr, both marked standalone) — researcher should clarify segment composition and verify if this represents discontinued operations or reporting structure

Margin recovery from -1.87% OPM (Jun 2026, main business) to breakeven on ₹446.85 Cr quarterly revenue base would unlock significant profitability — verify operational cost structure and pricing dynamics

Healthcare services sector typically benefits from rising spend and insurance adoption in India — researcher should verify company's market share trajectory and addressable market capture

Low leverage (D/E 0.03) provides capital efficiency for operational scaling — verify whether management has committed to growth capex and what ROI targets guide investment